Skip to main content
Top
Published in: Community Mental Health Journal 3/2008

01-06-2008 | Original Paper

Outcome from a Community-based Smoking Cessation Program for Persons with Serious Mental Illness

Authors: Shawn R. Currie, Jordyn Karltyn, Debra Lussier, Erin de Denus, Diane Brown, Nady el-Guebaly

Published in: Community Mental Health Journal | Issue 3/2008

Login to get access

Abstract

Six and 12-month outcomes are reported on 79 mentally ill persons attending either a 4- or 8-session community-based smoking cessation group. Quit rates at post, 3-, 6-, and 12-month follow-ups were 16, 19, 16, and 19%, respectively, with no significant effect of program length. These success rates are comparable to outcomes reported following group-based treatment with mentally healthy smokers. The majority of quitters used nicotine replacement therapy. Psychotropic medication dosages did not vary over time in quitters or non-quitters. No reductions in smoking were observed among non-quitters. Quitting smoking had no untoward effects on symptoms of mental illness or general functioning.
Literature
go back to reference Abrams, D. B., Niaura, R., Brown, R. A., Emmons, K. M., Goldstein, M. G., & Monti, P. M. (2003). The Tobacco Dependence Treatment Handbook. New York: Guilford Press. Abrams, D. B., Niaura, R., Brown, R. A., Emmons, K. M., Goldstein, M. G., & Monti, P. M. (2003). The Tobacco Dependence Treatment Handbook. New York: Guilford Press.
go back to reference Addington, J., el-Guebaly, N., Campbell, W., Hodgins, D., & Addington, D. (1998). Smoking cessation treatment for patients with schizophrenia. American Journal of Psychiatry, 155, 974–976.PubMed Addington, J., el-Guebaly, N., Campbell, W., Hodgins, D., & Addington, D. (1998). Smoking cessation treatment for patients with schizophrenia. American Journal of Psychiatry, 155, 974–976.PubMed
go back to reference American Psychiatric Association (1994). Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: Author. American Psychiatric Association (1994). Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: Author.
go back to reference Brown, S. (1997). Excess mortality of schizophrenia: A meta-analysis. British Journal of Psychiatry, 171, 502–508.PubMed Brown, S. (1997). Excess mortality of schizophrenia: A meta-analysis. British Journal of Psychiatry, 171, 502–508.PubMed
go back to reference de Leon, J., & Diaz, F. J. (2005). A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors. [References]. Schizophrenia Research, 76, 135–157.CrossRefPubMed de Leon, J., & Diaz, F. J. (2005). A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors. [References]. Schizophrenia Research, 76, 135–157.CrossRefPubMed
go back to reference Derogatis, L. R., & Melisaratos, N. (1983). The brief symptom inventory: An introductory report. Psychological Medicine, 130, 595–605.CrossRef Derogatis, L. R., & Melisaratos, N. (1983). The brief symptom inventory: An introductory report. Psychological Medicine, 130, 595–605.CrossRef
go back to reference Dubovsky, S. (2005). Benzodiazepine receptor agonists and antagonists. In B.J. Sadock, & V. A. Sadock (Eds.), Comprehensive Textbook of Psychiatry, (Vol. 2, 8th ed., pp. 2789). Philadelphia: Lippincott Williams & Wilkins. Dubovsky, S. (2005). Benzodiazepine receptor agonists and antagonists. In B.J. Sadock, & V. A. Sadock (Eds.), Comprehensive Textbook of Psychiatry, (Vol. 2, 8th ed., pp. 2789). Philadelphia: Lippincott Williams & Wilkins.
go back to reference Dursun, S., & Kutcher, S. (1999). Smoking, nicotine and psychiatric disorders: Evidence for therapeutic role, controversies and implications for future research. Medical Hypotheses, 52, 101–109.CrossRefPubMed Dursun, S., & Kutcher, S. (1999). Smoking, nicotine and psychiatric disorders: Evidence for therapeutic role, controversies and implications for future research. Medical Hypotheses, 52, 101–109.CrossRefPubMed
go back to reference el-Guebaly, N., Cathcart, J., Currie, S., Brown, D., & Gloster, S. (2001). Smoking cessation for individuals with mental illness or addictions. Psychiatric Services, 53, 1166–1170.CrossRef el-Guebaly, N., Cathcart, J., Currie, S., Brown, D., & Gloster, S. (2001). Smoking cessation for individuals with mental illness or addictions. Psychiatric Services, 53, 1166–1170.CrossRef
go back to reference el-Guebaly, N., & Hodgins, D. (1992). Schizophrenia and substance abuse: Prevalence issues. Canadian Journal of Psychiatry, 37, 704–710. el-Guebaly, N., & Hodgins, D. (1992). Schizophrenia and substance abuse: Prevalence issues. Canadian Journal of Psychiatry, 37, 704–710.
go back to reference Evins, A. E., Mays, V. K., Rigotti, N. A., Tisdale, T., Cather, C., & Goff, D. C. (2001). A pilot trial of bupropion added to cognitive behavioral therapy for smoking cessation schizophrenia. Nicotine & Tobacco Research, 3, 397–403.CrossRef Evins, A. E., Mays, V. K., Rigotti, N. A., Tisdale, T., Cather, C., & Goff, D. C. (2001). A pilot trial of bupropion added to cognitive behavioral therapy for smoking cessation schizophrenia. Nicotine & Tobacco Research, 3, 397–403.CrossRef
go back to reference Evins, A. E., Rigotti, N. A., Freudenreich, O., Henderson, D. C., Olm-Shipman, C. M., & Goff, D. C. (2004). Two-year follow-up of a smoking cessation trial in patients with schizophrenia: Increased rates of smoking cessation and reduction. Journal of Clinical Psychiatry, 65, 307–311.PubMedCrossRef Evins, A. E., Rigotti, N. A., Freudenreich, O., Henderson, D. C., Olm-Shipman, C. M., & Goff, D. C. (2004). Two-year follow-up of a smoking cessation trial in patients with schizophrenia: Increased rates of smoking cessation and reduction. Journal of Clinical Psychiatry, 65, 307–311.PubMedCrossRef
go back to reference George, T., Vessicchio, J. C., Termine, A., Bregartner, T. A., Feingold, A., Rounsaville, B. et al. (2002). A placebo controlled trial of bupropion for smoking cessation in schizophrenia. Biological Psychiatry, 52, 53–61.CrossRefPubMed George, T., Vessicchio, J. C., Termine, A., Bregartner, T. A., Feingold, A., Rounsaville, B. et al. (2002). A placebo controlled trial of bupropion for smoking cessation in schizophrenia. Biological Psychiatry, 52, 53–61.CrossRefPubMed
go back to reference George, T., Ziedonis, D., Feingold, A., Pepper, W., Satterburg, C., Winkel, J., & Kosten, T. (2000). Nicotine transdermal patch and atypical antipsychotic medications for smoking cessation in schizophrenia. American Journal of Psychiatry, 157, 1835–1842.CrossRefPubMed George, T., Ziedonis, D., Feingold, A., Pepper, W., Satterburg, C., Winkel, J., & Kosten, T. (2000). Nicotine transdermal patch and atypical antipsychotic medications for smoking cessation in schizophrenia. American Journal of Psychiatry, 157, 1835–1842.CrossRefPubMed
go back to reference Heatherton, T. F., Kozlowski, L., Frecker, R. C., & Fragerstrom, K. (1991). The Fagerstrom test for Nicotine Dependence: A revision of the Fagerstrom Tolerance Questionnaire. British Journal of Addiction, 86, 1119–1127.CrossRefPubMed Heatherton, T. F., Kozlowski, L., Frecker, R. C., & Fragerstrom, K. (1991). The Fagerstrom test for Nicotine Dependence: A revision of the Fagerstrom Tolerance Questionnaire. British Journal of Addiction, 86, 1119–1127.CrossRefPubMed
go back to reference Himelhoch, S., & Daumit, G. (2003). To whom do psychiatrists offer smoking-cessation counseling? Psychiatry, 160, 2228–2230. Himelhoch, S., & Daumit, G. (2003). To whom do psychiatrists offer smoking-cessation counseling? Psychiatry, 160, 2228–2230.
go back to reference Larsen, D., Attkinsson, C., Hargreaves, W., & Nguyen, T. (1979). Assessment of client/patient satisfaction: Development of a general scale. Evaluation and Program Planning, 2, 197–207.CrossRefPubMed Larsen, D., Attkinsson, C., Hargreaves, W., & Nguyen, T. (1979). Assessment of client/patient satisfaction: Development of a general scale. Evaluation and Program Planning, 2, 197–207.CrossRefPubMed
go back to reference Lasser, K., Boyd, W., Woolhandler, S., Himmelstein, D., McCormick, D., & Bor, D. (2000). Smoking and mental illness: a population-based prevalence study. JAMA, 284, 2606–2610.CrossRefPubMed Lasser, K., Boyd, W., Woolhandler, S., Himmelstein, D., McCormick, D., & Bor, D. (2000). Smoking and mental illness: a population-based prevalence study. JAMA, 284, 2606–2610.CrossRefPubMed
go back to reference Leonard, S., Breese, C., Adams, C., Benhammou, K., Gault, J., Stevens, K., Lee, M., Adler, L., Olincy, A., Ross, R., & Freedman, R. (2000). Smoking and schizophrenia: Abnormal nicotinic receptor expression. European Journal of Pharmacology, 393, 237–242.CrossRefPubMed Leonard, S., Breese, C., Adams, C., Benhammou, K., Gault, J., Stevens, K., Lee, M., Adler, L., Olincy, A., Ross, R., & Freedman, R. (2000). Smoking and schizophrenia: Abnormal nicotinic receptor expression. European Journal of Pharmacology, 393, 237–242.CrossRefPubMed
go back to reference MacKay, B. (2004). Butting out in Canada: Five down, eight to go. Canadian Medical Association Journal, 171, 558.CrossRefPubMed MacKay, B. (2004). Butting out in Canada: Five down, eight to go. Canadian Medical Association Journal, 171, 558.CrossRefPubMed
go back to reference McChargue, D. E., Gulliver, S. B., & Hitsman, B. (2002). Would smokers with schizophrenia benefit from a more flexible approach to smoking treatment. Addiction, 97, 785–793.CrossRefPubMed McChargue, D. E., Gulliver, S. B., & Hitsman, B. (2002). Would smokers with schizophrenia benefit from a more flexible approach to smoking treatment. Addiction, 97, 785–793.CrossRefPubMed
go back to reference Moll, S., Goldberg, J., Washington, A., & Pawlick, J. (1996). Smoking and people with mental health problems: A how-to guide for support people. Hamilton, ON: CSVR Foundation. Moll, S., Goldberg, J., Washington, A., & Pawlick, J. (1996). Smoking and people with mental health problems: A how-to guide for support people. Hamilton, ON: CSVR Foundation.
go back to reference Niaura, R., & Abrams, D. (2002). Smoking cessation: Progress, priorities, and prospectus. Journal of Consulting and Clinical Psychology, 70, 494–509.CrossRefPubMed Niaura, R., & Abrams, D. (2002). Smoking cessation: Progress, priorities, and prospectus. Journal of Consulting and Clinical Psychology, 70, 494–509.CrossRefPubMed
go back to reference Steinberg, M. L., Ziedonis, D. M., Krejci, J. A., & Brandon, T. H. (2004). Motivational interviewing with personalized feedback: A brief intervention for motivating smokers with schizophrenia to seek treatment for tobacco dependence. Journal of Consulting and Clinical Psychology, 72, 723–728.CrossRefPubMed Steinberg, M. L., Ziedonis, D. M., Krejci, J. A., & Brandon, T. H. (2004). Motivational interviewing with personalized feedback: A brief intervention for motivating smokers with schizophrenia to seek treatment for tobacco dependence. Journal of Consulting and Clinical Psychology, 72, 723–728.CrossRefPubMed
go back to reference Thorndike, A. N., Stafford, R. S., & Rigotti, N. A. (2001). US physicians’ treatment of smoking in outpatients with psychiatric diagnoses. Nicotine and Tobacco Research, 3, 85–91.CrossRefPubMed Thorndike, A. N., Stafford, R. S., & Rigotti, N. A. (2001). US physicians’ treatment of smoking in outpatients with psychiatric diagnoses. Nicotine and Tobacco Research, 3, 85–91.CrossRefPubMed
go back to reference Ventura, J., Lukoff, D., Nuechteriein, K., Liberman, R. P., Green, M. F., & Shaner, A. (1993). Manual for the expanded brief psychiatric rating scale (BPRS). International Journal of Methods in Psychiatric Research, 22, 1–20. Ventura, J., Lukoff, D., Nuechteriein, K., Liberman, R. P., Green, M. F., & Shaner, A. (1993). Manual for the expanded brief psychiatric rating scale (BPRS). International Journal of Methods in Psychiatric Research, 22, 1–20.
go back to reference Williams, J. M., & Hughes, J. (2003). Pharmacotherapy treatments for tobacco dependence among smokers with mental illness or addiction. Psychiatric Annals, 33, 457–466. Williams, J. M., & Hughes, J. (2003). Pharmacotherapy treatments for tobacco dependence among smokers with mental illness or addiction. Psychiatric Annals, 33, 457–466.
go back to reference Williams, J. M., & Ziedonis, D. (2004). Addressing tobacco among individuals with a mental illness or an addiction. Addictive Behaviors, 29, 1067–1083.CrossRefPubMed Williams, J. M., & Ziedonis, D. (2004). Addressing tobacco among individuals with a mental illness or an addiction. Addictive Behaviors, 29, 1067–1083.CrossRefPubMed
go back to reference Williams, J. M., Ziedonis, D. M., & Foulds, J. (2004). A case series of nicotine nasal spray in the treatment of tobacco dependence among patients with schizophrenia. Psychiatric Services, 55, 1064–1066.CrossRefPubMed Williams, J. M., Ziedonis, D. M., & Foulds, J. (2004). A case series of nicotine nasal spray in the treatment of tobacco dependence among patients with schizophrenia. Psychiatric Services, 55, 1064–1066.CrossRefPubMed
go back to reference Ziedonis, D., Kosten, T., Glazer, W., & Frances, R. (1994). Nicotine dependence and schizophrenia. Hospital and Community Psychiatry, 45, 204–206.PubMed Ziedonis, D., Kosten, T., Glazer, W., & Frances, R. (1994). Nicotine dependence and schizophrenia. Hospital and Community Psychiatry, 45, 204–206.PubMed
Metadata
Title
Outcome from a Community-based Smoking Cessation Program for Persons with Serious Mental Illness
Authors
Shawn R. Currie
Jordyn Karltyn
Debra Lussier
Erin de Denus
Diane Brown
Nady el-Guebaly
Publication date
01-06-2008
Publisher
Springer US
Published in
Community Mental Health Journal / Issue 3/2008
Print ISSN: 0010-3853
Electronic ISSN: 1573-2789
DOI
https://doi.org/10.1007/s10597-007-9113-8

Other articles of this Issue 3/2008

Community Mental Health Journal 3/2008 Go to the issue